This page is part of the FHIR Specification (v5.0.0-ballot: R5 Ballot - see ballot notes). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
Patient Care Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
Example of conditiondefinition
{ "resourceType": "ConditionDefinition", "id": "example", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ConditionDefinition</b><a name=\"example\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ConditionDefinition "example" </p></div><p><b>url</b>: <code>http://hl7.org/fhir/ConditionDefinition/example</code></p><p><b>identifier</b>: id: urn:oid:2.16.840.1.113883.4.642.25.1</p><p><b>name</b>: Hyperlipidemia</p><p><b>title</b>: Hyperlipidemia Status</p><p><b>status</b>: draft</p><p><b>date</b>: 2019-05-26T10:44:00+10:00</p><p><b>code</b>: Hyperlipidemia (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#55822004)</span></p><p><b>hasSeverity</b>: false</p><p><b>hasBodySite</b>: false</p><p><b>hasStage</b>: false</p><p><b>definition</b>: <a href=\"https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf\">https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf</a></p><blockquote><p><b>observation</b></p><p><b>code</b>: Lipid Panel <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#24331-1 "Lipid 1996 panel - Serum or Plasma")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Cholesterol <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#35200-5 "Cholesterol [Moles/volume] in Serum or Plasma")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Triglyceride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#35217-9 "Triglyceride [Moles/volume] in Serum or Plasma")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Cholesterol in HDL <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#2085-9 "HDL Cholesterol")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: LDL Chol. (Calc) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#13457-7 "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation")</span></p></blockquote><h3>Medications</h3><table class=\"grid\"><tr><td>-</td><td><b>Code</b></td></tr><tr><td>*</td><td>Gemfibrozil <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#203151)</span></td></tr></table><h3>Plans</h3><table class=\"grid\"><tr><td>-</td><td><b>Reference</b></td></tr><tr><td>*</td><td><a href=\"broken-link.html\">http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6</a></td></tr></table></div>" }, "url": "http://hl7.org/fhir/ConditionDefinition/example", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113883.4.642.25.1" } ], "name": "Hyperlipidemia", "title": "Hyperlipidemia Status", "status": "draft", "date": "2019-05-26T10:44:00+10:00", "code": { "coding": [ { "system": "http://snomed.info/sct", "code": "55822004", "display": "Hyperlipidemia (disorder)" } ] }, "hasSeverity": false, "hasBodySite": false, "hasStage": false, "definition": [ "https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf" ], "observation": [ { "code": { "coding": [ { "system": "http://loinc.org", "code": "24331-1", "display": "Lipid 1996 panel - Serum or Plasma" } ], "text": "Lipid Panel" } }, { "code": { "coding": [ { "system": "http://loinc.org", "code": "35200-5", "display": "Cholesterol [Moles/volume] in Serum or Plasma" } ], "text": "Cholesterol" } }, { "code": { "coding": [ { "system": "http://loinc.org", "code": "35217-9", "display": "Triglyceride [Moles/volume] in Serum or Plasma" } ], "text": "Triglyceride" } }, { "code": { "coding": [ { "system": "http://loinc.org", "code": "2085-9", "display": "HDL Cholesterol" } ], "text": "Cholesterol in HDL" } }, { "code": { "coding": [ { "system": "http://loinc.org", "code": "13457-7", "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation" } ], "text": "LDL Chol. (Calc)" } } ], "medication": [ { "code": { "coding": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "code": "203151", "display": "Gemfibrozil" } ] } } ], "plan": [ { "reference": { "reference": "http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6" } } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R5 Ballot hl7.fhir.core#5.0.0-ballot generated on Sat, Sep 10, 2022 05:02+1000.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4B |
Compare to R5 Draft |
|
Propose a change